Featured Research

from universities, journals, and other organizations

New Imaging Technique To Revolutionize Biomedical Optics

Date:
August 6, 2006
Source:
University Of Kent
Summary:
Kent Enterprise and the School of Physical Sciences at the University of Kent have spun out a high-tech company that is set to revolutionise biomedical optics. Optopod Ltd, the brainchild of Adrian Podoleanu, Professor of Biomedical Optics and Head of the Applied Optics Group in the School of Physical Sciences, has developed a technique based on optical coherence tomography (OCT) that has proved successful in non-destructive imaging of superficial tissue.

Kent Enterprise and the School of Physical Sciences at the University of Kent have spun out a high-tech company that is set to revolutionise biomedical optics.

Optopod Ltd, the brainchild of Adrian Podoleanu, Professor of Biomedical Optics and Head of the Applied Optics Group in the School of Physical Sciences, has developed a technique based on optical coherence tomography (OCT) that has proved successful in non-destructive imaging of superficial tissue.

Optopod's new technology has the great advantage that it is non-invasive and provides high-depth resolution, enabling safe application to different types of tissue -- such as skin, teeth, gum, internal vessel walls and hair -- and burns. The technology is also finding applications in biology and art conservation, with one recent experiment, conducted in association with the British Museum and the National Gallery, London, enabling scientists, conservationists and art historians to observe not only the structure of the varnish layer on a painting but also the different layers of paint and preparatory drawings beneath those layers. The technique is evolving rapidly and the University has applied for several patents to protect the technology.

Carole Barron, Director of Kent Enterprise said, 'Optopod Ltd, the second company that we have 'spun out' from the University of Kent within the last six months, consolidates our mission to commercially develop the University's intellectual property and world-class research.'

Karl Heeks, the University's technology transfer consultant who brokered the 'spin-out' said, 'Professor Podoleanu's international reputation in the area of biomedical optics and his well established commercial relationships have increased the likelihood of success for this exciting and revolutionary venture.'

Kent Enterprise is building very strong foundations in its technology transfer portfolio in a range of disciplines to enable future exploitation for the benefit of the University, its staff and the wider community.


Story Source:

The above story is based on materials provided by University Of Kent. Note: Materials may be edited for content and length.


Cite This Page:

University Of Kent. "New Imaging Technique To Revolutionize Biomedical Optics." ScienceDaily. ScienceDaily, 6 August 2006. <www.sciencedaily.com/releases/2006/08/060804104108.htm>.
University Of Kent. (2006, August 6). New Imaging Technique To Revolutionize Biomedical Optics. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/08/060804104108.htm
University Of Kent. "New Imaging Technique To Revolutionize Biomedical Optics." ScienceDaily. www.sciencedaily.com/releases/2006/08/060804104108.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins